Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Y-6 sublingual tablets in acute ischemic stroke
NCT07040085Phase 3Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Aug 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of dexborneol, cilostazol in ischemic stroke, sponsored by Beijing Tiantan Hospital. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
dexborneolcilostazol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07040085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07040085.